Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES (NCT07265999)
🩺 Plain-English Summary (8th-Grade Level)
Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.
Who can join: Review the eligibility criteria below.
Location: CHU de la Guadeloupe — Pointe-à-Pitre
Age range: 16 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- CHU de la Guadeloupe — Pointe-à-Pitre,
📞 Contact the Study Coordinator
Phone: +590590934667
Email: melanie.petapermal@chu-guadeloupe.fr
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dermatomyositis
- A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis — Oceanside, California
- A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — Phoenix, Arizona
- Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis — Palo Alto, California
- Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis — Cleveland, Ohio
- Adult and Juvenile Myositis — Atlanta, Georgia
- Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) — Philadelphia, Pennsylvania
Explore by condition: All Dermatomyositis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.